Broader European trend🤞7 Mar 2024 18:27
Germany’s legislative changes as a catalyst for the cannabis industry’s growth, projecting a leap from a 28,000 patient base in 2023 to a market worth €1.7 billion by 2025. His review of Germany’s phased legalization approach, beginning with personal use and potentially extending to retail sales, offers a foundation for understanding investment avenues.
Spotlight on Investment Prospects The expected rise in medical cannabis users in Germany signifies a broader European trend, where access and pricing dynamics are key market drivers. Zuanic highlights companies such as Aurora, Tilray, and Curaleaf International Holdings Limited as front-runners poised to benefit from these developments. His insights act as a guide for investors aiming to make informed decisions in a shifting market. #seedinnov